HK1056362A1 - Triazolo Ä4,5-dÜ pyrimidine derivatives as anti-thrombotic agents - Google Patents

Triazolo Ä4,5-dÜ pyrimidine derivatives as anti-thrombotic agents

Info

Publication number
HK1056362A1
HK1056362A1 HK03108714A HK03108714A HK1056362A1 HK 1056362 A1 HK1056362 A1 HK 1056362A1 HK 03108714 A HK03108714 A HK 03108714A HK 03108714 A HK03108714 A HK 03108714A HK 1056362 A1 HK1056362 A1 HK 1056362A1
Authority
HK
Hong Kong
Prior art keywords
triazolo
pyrimidine derivatives
thrombotic agents
thrombotic
agents
Prior art date
Application number
HK03108714A
Other languages
English (en)
Inventor
Roger Brown
Simon Guile
Garry Pairaudeau
Brian Springthorpe
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of HK1056362A1 publication Critical patent/HK1056362A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK03108714A 2000-11-09 2003-11-28 Triazolo Ä4,5-dÜ pyrimidine derivatives as anti-thrombotic agents HK1056362A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0004099A SE0004099D0 (sv) 2000-11-09 2000-11-09 Novel compounds
PCT/SE2001/002471 WO2002038570A1 (en) 2000-11-09 2001-11-07 Novel compounds

Publications (1)

Publication Number Publication Date
HK1056362A1 true HK1056362A1 (en) 2004-02-13

Family

ID=20281756

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03108714A HK1056362A1 (en) 2000-11-09 2003-11-28 Triazolo Ä4,5-dÜ pyrimidine derivatives as anti-thrombotic agents

Country Status (10)

Country Link
US (1) US7034032B2 (xx)
EP (1) EP1335919B1 (xx)
JP (1) JP4202752B2 (xx)
AT (1) ATE345343T1 (xx)
AU (1) AU2002214467A1 (xx)
DE (1) DE60124581T2 (xx)
ES (1) ES2274908T3 (xx)
HK (1) HK1056362A1 (xx)
SE (1) SE0004099D0 (xx)
WO (1) WO2002038570A1 (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0219746D0 (en) * 2002-08-23 2002-10-02 Inst Of Ex Botany Ascr Azapurine derivatives
GB0512844D0 (en) * 2005-06-23 2005-08-03 Novartis Ag Organic compounds
US7752475B2 (en) * 2006-06-27 2010-07-06 International Business Machines Corporation Late data launch for a double data rate elastic interface
US7734944B2 (en) * 2006-06-27 2010-06-08 International Business Machines Corporation Mechanism for windaging of a double rate driver
JP2010508350A (ja) 2006-10-31 2010-03-18 ヤンセン ファーマシューティカ エヌ．ベー． Ａｄｐｐ２ｙ１２レセプターアンタゴニストとしてのトリアゾロピリミジン誘導体

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8826205D0 (en) * 1988-11-09 1988-12-14 Wellcome Found Heterocyclic compounds
AR017014A1 (es) * 1997-07-22 2001-08-22 Astrazeneca Ab Compuestos de triazolo [4,5-d]pirimidina, composiciones farmaceuticas, uso de los mismos para preparar medicamentos y procesos para la preparacionde dichos compuestos

Also Published As

Publication number Publication date
US7034032B2 (en) 2006-04-25
EP1335919A1 (en) 2003-08-20
US20040023988A1 (en) 2004-02-05
ES2274908T3 (es) 2007-06-01
AU2002214467A1 (en) 2002-05-21
DE60124581T2 (de) 2007-06-28
DE60124581D1 (de) 2006-12-28
ATE345343T1 (de) 2006-12-15
SE0004099D0 (sv) 2000-11-09
EP1335919B1 (en) 2006-11-15
JP2004513172A (ja) 2004-04-30
JP4202752B2 (ja) 2008-12-24
WO2002038570A1 (en) 2002-05-16

Similar Documents

Publication Publication Date Title
AU2002305143A1 (en) Pyrazolo'1,5-a!pyridine derivatives
CA2296665A1 (en) Triazolo[4,5-d]pyrimidine derivatives as anti-thromobotic agents
WO2003095455A3 (en) Substituted pyrazolopyrimidines
MY140674A (en) New crystalline form of a triazolo(4,5-d)pyrimidine compound
PL366827A1 (en) Imidazo[1,2-a]pyridine derivatives for the prophylaxis and treatment of herpes viral infections
WO2002048147A3 (en) Pyrazolopyridines
TW200510417A (en) Nitrogen-substituted hexahydropyrazino[1,2-a]pyrimidine-4, 7-dione derivatives, processes for their preparation and their use as medicaments
TW200508235A (en) Substituted hexahydropyrazino[1, 2-a]pyrimidine-4, 7-dione derivatives, processes for their preparation and their use as medicaments
MY121867A (en) Novel triazolo(4,5-d)pyrimidine compounds.
WO2002006286A3 (en) IMIDAZO[1,2-a]PYRAZINES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
HK1048990A1 (en) Novel compounds.
WO2004112719A3 (en) Chemical compounds
WO2002048148A3 (en) Pyrazolopyridine derivatives
MXPA04001773A (es) Derivados de 6,7-dihidroxitetrahidroisquinolinas 3-sustituidas parta uso como agentes antibacterianos.
DE69911785D1 (de) Triazolo[4,5-d]pyrimidin-verbindungen
IL173629A0 (en) Imidazo(4,5-b) pyridine derivatives and pharmaceutical compositions containing the same
HK1056362A1 (en) Triazolo Ä4,5-dÜ pyrimidine derivatives as anti-thrombotic agents
UA84300C2 (ru) ПРОИЗВОДНЫЕ ГЕКСА- И ОКТАГИДРОПИРИДО[1,2-a]ПИРАЗИНА С АНТАГОНИСТИЧЕСКОЙ АКТИВНОСТЬЮ ОТНОСИТЕЛЬНО NK1
AU2002248531A1 (en) Pyrazolopyriadine derivatives
WO2003045940A3 (en) Benzazepine derivatives and their use as 5-ht ligands
HUP0303486A3 (en) Compositions containing 3,7-diazabicyclo [3,3,1] compounds as anti-arrythmic compounds agents
CA2299036A1 (en) 4-phenyl-4-heteroarylpiperidine derivatives
HK1056361A1 (en) Novel compounds
PL1603907T3 (pl) Podstawione pirydo[1,2-a]pirymidyny i ich zastosowanie jako inhibitorów-NOS
WO2000078751A3 (en) Compounds for use in treatment of neurological disorders

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20101107